Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > GLS Gelesis Holdings > Detailed Quotes

GLS Gelesis Holdings

Watchlist
1.140
+0.010+0.88%
Close 10/04 16:00 ET
1.14000.00%
Post Mkt Price 10/04 16:02 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
1.200
Open
1.100
Turnover
29.75K
Low
1.100
Pre Close
1.130
Volume
25.96K
Market Cap
83.16M
P/E(TTM)
Loss
52wk High
12.230
Shares
72.95M
P/E(Static)
Loss
52wk Low
1.010
Float Cap
22.42M
Bid/Ask %
-33.33%
Historical High
12.230
Shs Float
19.67M
Volume Ratio
0.57
Historical Low
1.010
Dividend TTM
--
Div Yield TTM
--
P/B
16.29
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.13%
Amplitude
8.85%
Avg Price
1.146
Lot Size
1
Float Cap
22.42M
Bid/Ask %
-33.33%
Historical High
12.230
Shs Float
19.67M
Volume Ratio
0.57
Historical Low
1.010
Dividend TTM
--
P/B
16.29
Dividend LFY
--
Turnover Ratio
0.13%
Amplitude
8.85%
Avg Price
1.146
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.
CEO: Zohar, Yishai
Market: NYSE
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top